Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule acetamide derivative with a complex heterocyclic structure, including pyrazine and pyridine rings substituted with chloro, fluoro, and difluoropyridinylethyl groups. It is classified as an aminopyrazine and has been cataloged in chemical databases such as DrugBank (DB07548) and ChemSpider. There are no approved indications or clinical trials reported for this molecule; it remains an experimental compound with no known therapeutic use or mechanism of action described in the literature[2][4][5]. No information on its pharmacology, targets, or biological activity is available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-(6-chloro-3-{[2,2-difluoro-2-(2-pyridinyl)ethyl]amino}-2-oxo-1(2H)-pyrazinyl)-N-[(2-fluoro-6-pyridinyl)methyl]acetamide.